Table 1.
Characteristics of 512 patients with gastric cancer with an SRC component.
| Variables | Value (%) |
|---|---|
| Sex | |
| Men | 332 (64.8) |
| Women | 180 (35.2) |
| Age (years) | |
| <55 | 246 (48.0) |
| ≥55 | 266 (52.0) |
| SRCC | |
| pSRCC | 68 (13.3) |
| mSRCC | 444 (86.7) |
| Chemotherapy | |
| Yes | 244 (47.7) |
| No | 268 (52.3) |
| Tumor size(cm) | |
| <4.75 | 228 (44.5) |
| ≥4.75 | 284 (55.5) |
| pT | |
| T1 | 84 (16.4) |
| T2 | 64 (12.5) |
| T3 | 62 (12.1) |
| T4 | 302 (59.0) |
| pN | |
| N0 | 166 (32.4) |
| N1 | 86 (16.8) |
| N2 | 100 (19.5) |
| N3a | 102 (19.9) |
| N3b | 58 (11.4) |
| pTNM | |
| I+II | 220 (43.0) |
| III | 292 (57.0) |
| Tumor location | |
| Lower stomach | 328 (64.1) |
| Middle stomach | 75 (14.6) |
| Upper stomach | 35 (6.8) |
| LM stomach | 53 (10.3) |
| MU stomach | 7 (1.4) |
| LMU stomach | 14 (2.8) |
| Leukocyte | |
| <6.17 | 292 (57.0) |
| ≥6.17 | 220 (43.0) |
| Neutrophil | |
| <3.27 | 260 (50.8) |
| ≥3.27 | 252 (49.2) |
| Hemoglobin | |
| <121.2 | 140 (27.3) |
| ≥121.2 | 372 (72.7) |
| Fibrinogen | |
| <3.06 | 268 (52.3) |
| ≥3.06 | 244 (47.7) |
| Prealbumin | |
| <234.5 | 247 (48.2) |
| ≥234.5 | 265 (51.8) |
| Albumin | |
| <42.5 | 292 (57.0) |
| ≥42.5 | 220 (43.0) |
| Globulin | |
| <29.9 | 425 (83.0) |
| ≥29.9 | 87 (17.0) |
| SII | |
| <527 | 340 (66.4) |
| ≥527 | 172 (33.6) |
| PNI | |
| <48.73 | 176 (34.4) |
| ≥48.73 | 336 (65.6) |
| Total gastrectomy | |
| Yes | 113 (22.1) |
| No | 399 (77.9) |
| NLR | |
| <2.2 | 340 (66.4) |
| ≥2.2 | 172 (33.6) |
SRC: signet-ring cell; SRCC: signet-ring cell carcinoma; pSRCC: pure signet-ring cell cancer; mSRCC: mixed signet-ring cell cancer; LM: lower and middle; MU: middle and upper; LMU: lower, middle, and upper; SII: systemic immune-inflammation index; PNI: prognostic nutritional index; NLR: lymphocyte to neutrophil ratio.